FDA Adverse Event Injury Summary report: N

UNKNOWN OPTEASE VENA CAVA FILTER

MDR report key: 2429148 · Received January 26, 2012

Report

Report Number
9616099-2012-00045
Event Type
Injury
Date Received
January 26, 2012
Date of Event
December 28, 2011
Report Date
January 10, 2012
Manufacturer
CORDIS DE MEXICO
Product Code
DTK
PMA / PMN Number
UNK
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

PHLEBOGRAPHY THROUGH THE RIGHT FEMORAL VEIN SHOWED THROMBUS IN THE LEFT COMMON ILIAC VEIN, WHICH EXTENDED INTO THE RIGHT COMMON ILIAC VEIN, AND THUS, FILTER PLACEMENT WAS PERFORMED THROUGH THE RIGHT JUGULAR VEIN. AFTER 4 DAYS, THE SYMPTOMS OF THE PATIENT HAD DECREASED SUBSTANTIALLY AND FILTER RETRIEVAL WAS PLANNED. THE CATALOG AND LOT NUMBERS FOR THE ACTUAL PRODUCT USED IN THE PROCEDURE ARE UNKNOWN. CONCOMITANT DEVICES (RETRIEVAL PROCEDURE): 5-F PIER CATHETER, 0.035 INCH HYDROPHILIC GUIDEWIRE (TERUMO, (B)(4)),A 0.035 INCH STIFF AMPLATZ GUIDEWIRE (COOK, (B)(4)) AND A CORDIS 12 MM OPTA PTA BALLOON. THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. ADDITIONALLY, AS THE STERILE LOT NUMBER WAS NOT AVAILABLE, DEVICE HISTORY RECORD REVIEW COULD NOT BE PERFORMED. NO CORRECTIVE OR PREVENTIVE ACTION WILL BE TAKEN, GIVEN THAT; WITH THE INFORMATION PROVIDED THE REPORTED FAILURE/EVENT DOES NOT APPEAR TO BE RELATED TO THE MANUFACTURING PROCESS. FILTER TILTING IS A KNOWN POTENTIAL COMPLICATION OF THIS TYPE OF PROCEDURE AND IS LISTED IN THE IFU AS SUCH AND OCCURS IN APPROXIMATELY 5.5% OF ALL CASES. TYPICALLY, FILTER TILT CAN LEAD TO A PROLONGED RETRIEVAL TIME AND HAS NO ADVERSE EFFECT UPON THE PATIENT. IT IS UNKNOWN IF THERE WERE DEPLOYMENT, VESSEL OR PROCEDURAL ISSUES THAT PRE-DISPOSED THE FILTER TO TILT. AS SUCH, WITH THE INFORMATION PROVIDED IS NOT POSSIBLE TO DRAW A CLINICAL CONCLUSION BETWEEN THE DEVICE AND THE EVENT.

Description of Event or Problem · 1

VINK ET AL IN BALLOON-ASSISTED RETRIEVAL OF TILTED OPTEASE IVC FILTER, CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, DOI: 10.1007/S00270-011-0332-6ONLINE FIRST. REPORT 4 DAYS AFTER A PATIENT WAS TREATED WITH AN OPTEASE FILTER; PHLEBOGRAPHY THROUGH THE RIGHT FEMORAL VEIN DID NOT SHOW ANY RESIDUAL THROMBOSIS. HOWEVER, THE OPTEASE IVC FILTER WAS TILTED TO THE RIGHT SIDE OF THE INFRARENAL CAVAL WALL AND COULD NOT BE RETRIEVED BY USING THE CONVENTIONAL SNARING TECHNIQUE. WITH THE SAME BALLOON-ASSISTED TECHNIQUE AS DESCRIBED IN THE FIRST CASE, THE TILT OF THE FILTER COULD BE NEUTRALIZED, THE HOOK OF THE IVC FILTER BECAME ACCESSIBLE, AND THE FILTER COULD BE REMOVED SAFELY. THE IVC FILTER WAS CATHETERIZED THROUGH THE CONTRALATERAL LEFT COMMON FEMORAL VEIN WITH A 5-F PIER CATHETER AND A 0.035 INCH HYDROPHILIC GUIDEWIRE (TERUMO, (B)(4)), WHICH WAS SUBSEQUENTLY EXCHANGED FOR A 0.035 INCH STIFF AMPLATZ GUIDEWIRE (COOK, (B)(4)). UNDER FLUOROSCOPIC GUIDANCE, A 12 MM OPTA PTA BALLOON (CORDIS) WAS ADVANCED OVER THE GUIDEWIRE THROUGH THE STRUTS OF THE FILTER INTO ITS LUMEN AND WAS SUBSEQUENTLY INFLATED WITH A MIX OF CONTRAST MATERIAL (50%) AND SALINE (50%). GENTLE TRACTION ON THE BALLOON CATHETER ENABLED US TO NEUTRALIZE THE POSITION OF THE FILTER WITHIN THE IVC AND TO REMOVE THE TILT IN RELATION TO THE CAVAL WALL. WITH CONTINUED TRACTION FROM THE LEFT SIDE, IT WAS RELATIVE EASY TO SNARE THE HOOK OF THE FILTER AND THE FILTER COULD BE REMOVED IN THE NORMAL FASHION THROUGH THE RIGHT FEMORAL SIDED GUIDING CATHETER. THE PATIENT WAS A 29(B)(6) WOMAN WHO PRESENTED WITH A PAINFUL MASSIVE THROMBUS IN THE LEFT COMMON ILIAC VEIN AND COMPRESSION OF THE PROXIMAL PART OF THE VEIN BY THE LEFT COMMON ILIAC ARTERY, SUGGESTIVE OF A MAY-THURNER SYNDROME. INITIAL PERCUTANEOUS INTRAVENOUS THROMBOLYSIS WAS PLANNED, PRECEDED BY THE PLACEMENT OF A RETRIEVABLE OPTEASE FILTER TO PREVENT PULMONARY EMBOLISM DUE TO CLOT INSTABILITY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNKNOWN OPTEASE VENA CAVA FILTER THROMBECTOMY SYSTEMS (DTK) DTK CORDIS DE MEXICO NA UNK

Patients

Seq Age Sex Outcome Treatment
1 29 YR Life Threatening| R